Published in Health Serv Res on February 01, 1999
Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2012) 1.88
A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs. Health Serv Res (2002) 1.14
The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ (2007) 0.91
Longitudinal analysis of efficiency in multiple output dialysis markets. Health Care Manag Sci (2004) 0.86
Is case-mix adjustment necessary for an expanded dialysis bundle? Health Care Financ Rev (2003) 0.83
Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers. BMC Health Serv Res (2013) 0.80
Predictors of chain acquisition among independent dialysis facilities. Health Serv Res (2010) 0.79
Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol (2016) 0.75
Cost functions for dialysis facilities and the quality of dialysis. Health Serv Res (1999) 0.75
For-profit status and industry evolution in health care markets: evidence from the dialysis industry. Int J Health Econ Manag (2016) 0.75
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med (1993) 4.88
A national survey of the arrangements managed-care plans make with physicians. N Engl J Med (1995) 4.82
Refining a case-mix measure for nursing homes: Resource Utilization Groups (RUG-III). Med Care (1994) 4.77
Mortality and duration of hemodialysis treatment. JAMA (1991) 2.94
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Risk contracts in managed mental health care. Health Aff (Millwood) (1995) 1.42
The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. Health Serv Res (1994) 1.22
Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int (1996) 1.17
The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care (1992) 1.17
Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA (1996) 1.13
Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis (1994) 1.03
Price of dialysis, unit staffing, and length of dialysis treatments. Am J Kidney Dis (1990) 0.98
Payment source and the cost of hospital care: evidence from a multiproduct cost function with multiple payers. J Health Econ (1996) 0.95
Competition under fixed prices: effects on patient selection and service strategies by hemodialysis providers. Med Care Res Rev (1996) 0.92
From the Health Care Financing Administration. JAMA (1995) 0.91
Dialysis outcomes in works. HCFA may set quality, practice guidelines for ESRD program. Mod Healthc (1997) 0.84
Some of the small print on managed care proposals for end-stage renal disease. Adv Ren Replace Ther (1997) 0.83
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Lack of health insurance and decline in overall health in late middle age. N Engl J Med (2001) 3.45
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Hemodialysis vascular access morbidity in the United States. Kidney Int (1993) 1.41
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
Containing Medicaid costs in an era of growing physician supply. Health Care Financ Rev (1985) 1.33
Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis (1997) 1.29
Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int (1996) 1.27
Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int (1999) 1.25
Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17
Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int (1996) 1.17
The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care (1992) 1.17
Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int (1992) 1.17
The costs of Medicare patients in nursing homes in the United States: multiple output analysis. J Health Econ (1989) 1.14
Hospital-insurer bargaining: an empirical investigation of appendectomy pricing. J Health Econ (1997) 1.05
The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial (2001) 1.05
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Alzheimer Dis Assoc Disord (1998) 1.05
Calculation and public use of the unit-specific standardized mortality ratio. Am J Kidney Dis (2001) 1.02
Understanding the recent growth in Medicare physician expenditures. JAMA (1990) 1.01
Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01
Renal transplantation in end-stage sickle cell nephropathy. Transplantation (1999) 1.01
Benign moral hazard and the cost-effectiveness analysis of insurance coverage. J Health Econ (1990) 1.01
Should Medicare compensate hospitals for administratively necessary days? Milbank Q (1989) 0.99
[Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis]. Nephrologie (2001) 0.98
Non-price rationing and the choice of medical care providers in rural Côte d'Ivoire. J Health Econ (1987) 0.97
Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int (1996) 0.97
Ownership, competition, and the adoption of new technologies and cost-saving practices in a fixed-price environment. Inquiry (2000) 0.95
The United States Renal Data System's 1991 annual data report: an introduction. Am J Kidney Dis (1991) 0.94
Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis (1998) 0.93
Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis (2001) 0.92
Ownership of dialysis facilities and patients' survival. N Engl J Med (2000) 0.90
The relationship between alternative medication possession ratio thresholds and outcomes: evidence from the use of glatiramer acetate. J Med Econ (2011) 0.88
Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection. Kidney Int (1995) 0.87
A critical examination of trends in outcomes over the last decade. Am J Kidney Dis (1998) 0.86
Some of the small print on managed care proposals for end-stage renal disease. Adv Ren Replace Ther (1997) 0.83
Has PPS increased Medicare expenditures on physicians? J Health Polit Policy Law (1991) 0.82
Medicare costs in urban and rural nursing homes: are differential payments required? Inquiry (1994) 0.81
Using USRDS generated hospitalization tables to compare local dialysis patient hospitalization rates to national rates. Kidney Int (1996) 0.81
Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes. Transplantation (1997) 0.80
Characteristics and treatment of patients not reusing dialyzers in reuse units. Am J Kidney Dis (2000) 0.80
The impact of nonidentical ABO cadaveric renal transplantation on waiting times and graft survival. Am J Kidney Dis (1991) 0.80
Excerpts from United States Renal Data System 1995 Annual Data Report. Am J Kidney Dis (1995) 0.80
Enzyme-resistant CCK analogs with high affinities for central receptors. Peptides (1989) 0.79
Continuous ambulatory peritoneal dialysis: preliminary evidence in the debate over efficacy and cost. Health Aff (Millwood) (1983) 0.79
Cyclic cholecystokinin analogues with high selectivity for central receptors. Proc Natl Acad Sci U S A (1988) 0.79
Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. J Med Chem (1989) 0.78
Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease program. Milbank Q (1987) 0.77
The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. Eur J Pharmacol (1989) 0.77
The study of outcomes for CAPD versus hemodialysis patients. Perit Dial Int (1997) 0.77
End-stage renal disease in the USA: data from the United States Renal Data System. Am J Nephrol (1996) 0.77
[Role of the autonomic nervous system (adrenergic, cholinergic and nonadrenergic, noncholinergic) in regulation of respiratory system function]. Postepy Hig Med Dosw (1995) 0.77
Growth rates in pediatric dialysis patients and renal transplant recipients. Am J Kidney Dis (1997) 0.76
How available are evening dialysis services? Health Care Financ Rev (1985) 0.75
Privatization and bidding in the health-care sector. J Policy Anal Manage (1987) 0.75
The role of HLA matching for cadaveric renal transplants in the cyclosporine era. Semin Nephrol (1992) 0.75
Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue. J Med Chem (1989) 0.75
Juries and justice: are malpractice and other personal injuries created equal? Law Contemp Probl (1992) 0.75
Prepaid medical practice: a summary of findings from a recent survey of group practices in the United States. A comparison of fee-for-service and prepaid groups. Group Health J (1980) 0.75
[Clinical manifestations, diagnosis and treatment of exercise induced asthma]. Pneumonol Alergol Pol (1996) 0.75
Calculation and public use of the unit-specific standardized mortality ratio. Am J Kidney Dis (2001) 0.75
[Diagnostic standard for differentiation between bronchial asthma and chronic obstructive pulmonary disease]. Pneumonol Alergol Pol (1998) 0.75
Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: relationships with affinity and selectivity for brain receptors. Biopolymers (1989) 0.75
Production of leukotriene C4 by peripheral blood leukocytes stimulated with anti-fcepsilonRI antibody, PMA, and fMLP does not correlate with irreversible airway obstruction in asthmatics. J Investig Allergol Clin Immunol (2007) 0.75
The United States Renal Data System's 1990 Annual Data Report: an introduction. Am J Kidney Dis (1990) 0.75
Analysis of economic performance in medical group practices: 1. executive summary. Med Group Manage (1980) 0.75
[The evaluation of concentration myeloperoxidase and interleukin-8 in blood serum of pregnant women with or without pregnancy induced hypertension]. Ginekol Pol (1998) 0.75
Synthesis and biological activity of CCK26-33-related analogues modified in position 31. J Med Chem (1988) 0.75
Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation. Am J Kidney Dis (1994) 0.75